GlassScriptPhysician profile
Sarah B Young
NPI 1477630523
$1,682.72
in general payments reported to CMS, 2019-2025
11 companies · $382 in 2025
The $382 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $38.41 · 2021: $87.72 · 2023: $41.71 · 2024: $1,133 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $915 · Food and Beverage: $557 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $914.77 |
| Food and Beverage | $556.83 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $996.67 | 2023-2024 | Gelpoint V-Path |
| Abbvie INC. | $251.03 | 2019-2025 | |
| Astellas Pharma US INC | $161.88 | 2024-2025 | Veozah |
| Biogen, INC. | $75.45 | 2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $43.52 | 2024-2025 | Myfembree |
| Daiichi Sankyo INC. | $43.37 | 2024-2025 | Injectafer |
| Exact Sciences Corporation | $39.29 | 2024-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Organon LLC | $21.93 | 2024 | |
| Merck Sharp & Dohme LLC | $19.55 | 2019 | |
| Novo Nordisk INC | $16.74 | 2024 | |
| Hologic Sales and Service, LLC | $13.29 | 2024 | Myosure Tissue Removal Device, Omni Hysteroscope |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.